Quantitation of uterine activity after vaginal administration of prostaglandins.
D000028:Abortion, Induced; D003338:Corpus Luteum / Q000187:drug effects; D005260:Female; D005313:Fetal Death; D006801:Humans; D006828:Hydatidiform Mole; D007275:Injections, Intravenous; D008183:Luteal Phase; D009129:Muscle Tonus / Q000187:drug effects; D011247:Pregnancy; D011453:Prostaglandins / Q000494:pharmacology*; D011458:Prostaglandins E / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D011460:Prostaglandins F / Q000008:administration & dosage / Q000494:pharmacology; D013488:Suppositories; D013997:Time Factors; D014590:Uterine Contraction / Q000187:drug effects; D014621:Vagina
D011453:Prostaglandins; D011458:Prostaglandins E; D011460:Prostaglandins F; D013488:Suppositories